| [1] |
Salminen P, Kow L, Aminian A, et al.IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management-an International Delphi Study[J].Obes Surg, 2024, 34(1): 30-42.
|
| [2] |
Global burden of 87 risk factors in 204 countries and territories,1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet, 2020, 396(10258): 1223-1249.
|
| [3] |
Heitmann B L, Køster-Rasmussen R, Meyer L B, et al.Debating Weight Loss vs.Weight Neutral Strategies for Improvements of Health[J].Curr Obes Rep, 2024, 13(4): 832-842.
|
| [4] |
Lee M, Lauren BN, Zhan T, et al.The cost-effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity[J].Obes Sci Pract, 2020, 6(2): 162-170.
|
| [5] |
Jirapinyo P, Hadefi A, Thompson C C, et al.American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity[J].Gastrointest Endosc, 2024, 99(6):867-885.e64.
|
| [6] |
Wiggins T, Sharma O, Sarfaraz Y, et al.Safety and Efficacy of 12-Month Intra-gastric Balloon-Series of over 1100 Patients[J].Obes Surg, 2024, 34(1): 176-182.
|
| [7] |
叶宁.ReShape 胃内双球囊系统[J].中国医疗设备, 2015, 30(10):183-184.
|
| [8] |
Fittipaldi-Fernandez R J, Zotarelli-Filho I J, Diestel C F, et al.Randomized Prospective Clinical Study of Spatz3® Adjustable Intragastric Balloon Treatment with a Control Group: a Large-Scale Brazilian Experiment[J].Obes Surg, 2021, 31(2): 787-796.
|
| [9] |
Swei E, Almuhaidb A, Sullivan S, et al.Comparison of the Efficacy and Safety of the FDA-approved Intragastric Balloon Systems in a Clinical Setting[J].J Clin Gastroenterol, 2023, 57(6): 578-585.
|
| [10] |
Machytka E, Gaur S, Chuttani R, et al.Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational,open-label, multicenter study[J].Endoscopy, 2017, 49(2): 154-160.
|
| [11] |
Dejeu D, Dejeu P, Bradea P, et al.Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion's Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker[J].Clin Pract, 2024, 14(3): 765-778.
|
| [12] |
Jense MTF, Palm-Meinders IH, Sanders B, et al.The Swallowable Intragastric Balloon Combined with Lifestyle Coaching: Short-Term Results of a Safe and Effective Weight Loss Treatment for People Living with Overweight and Obesity[J].Obes Surg, 2023, 33(6):1668-1675.
|
| [13] |
Vašura A, Machytka E, Urban O, et al.Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD-a prospective interventional study[J].Ann Hepatol, 2024, 30(1):101765.
|
| [14] |
Van Dijk A M, De Vries M, El-Morabit F, et al.Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease[J].Intern Emerg Med, 2023, 18(8): 2271-2280.
|
| [15] |
Soroceanu RP, Timofte DV, Maxim M, et al.Twelve-Month Outcomes in Patients with Obesity Following Bariatric Surgery-A Single Centre Experience[J].Nutrients, 2023, 15(5): 1134.
|
| [16] |
Shah RH, Vedantam S, Kumar S, et al.Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis[J].Obes Surg, 2023, 33(3): 725-732.
|
| [17] |
Moore RL, Eaton L, Ellner J.Safety and Effectiveness of an Intragastric Balloon as an Adjunct to Weight Reduction in a Post-Marketing Clinical Setting[J].Obes Surg, 2020, 30(11):4267-4274.
|
| [18] |
Berger ME, Løve US.Gastric perforation during second intragastric balloon treatment: a case report[J].AME Case Rep, 2022, 6: 15.
|
| [19] |
Brizuela L, Samarah H, Cardona N.Small Bowel Obstruction Following Dislodgement of an Intragastric Balloon: A Case Report[J].Cureus, 2024, 16(8): e67738.
|
| [20] |
Yahia Y, Abuodeh J, Chandra P, et al.Risk Factors for Acute Pancreatitis Following Intragastric Balloon Insertion: A 7-Year Retrospective Cohort Study[J].Obes Surg, 2025, 35(2): 496-504.
|
| [21] |
Choo A, Lim E, Eng A, et al.Predictors of early removal of intragastric balloon due to intolerance: Insights from a multiethnic Asian cohort[J].Ann Acad Med Singap, 2024, 53(9): 551-561.
|
| [22] |
Mohapatra S, Mirza MA, Hilles AR, et al.Biomedical Application,Patent Repository, Clinical Trial and Regulatory Updates on Hydrogel: An Extensive Review[J].Gels, 2021, 7(4): 207.
|
| [23] |
Tang R C, Chen TC, Lin FH.Design Strategy for a Hydroxide-Triggered pH-Responsive Hydrogel as a Mucoadhesive Barrier to Prevent Metabolism Disorders[J].ACS Appl Mater Interfaces, 2021, 13(49): 58340-58351.
|
| [24] |
Ard JD, Ryan DH, O'neil PM, et al.Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study[J].Obesity(Silver Spring), 2025,33(3): 500-511.
|
| [25] |
Giruzzi N.Plenity(Oral Superabsorbent Hydrogel)[J].Clin Diabetes,2020, 38(3): 313-314.
|
| [26] |
Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al.Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity(MERIT): a prospective, multicentre, randomised trial[J].Lancet, 2022,400(10350): 441-451.
|
| [27] |
Dayyeh BKA, Stier C, Alqahtani A, et al.IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management[J].Obes Surg, 2024, 34(12): 4318-4348.
|
| [28] |
Abu Dayyeh BK, Rajan E, Gostout CJ.Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity[J].Gastrointest Endosc, 2013,78(3): 530-535.
|
| [29] |
Gala K, Brunaldi V, Abu Dayyeh BK.Novel Devices for Endoscopic Suturing: Past, Present, and Future[J].Gastrointest Endosc Clin N Am, 2024, 34(4): 733-742.
|
| [30] |
Kantsevoy SV.The Development of the Overstitch System and Its Potentials[J].Gastrointest Endosc Clin N Am, 2020, 30(1): 107-114.
|
| [31] |
Keihanian T, Othman MO.OverStitch Sx Endoscopic suturing system in minimally invasive endoscopic procedures: overview of its safety and efficacy and comparison to oversticth(TM)[J].Expert Rev Med Devices, 2022, 19(1): 11-23.
|
| [32] |
Maselli R, Palma R, Traina M, et al.Endoscopic suturing for GI applications: initial results from a prospective multicenter European registry[J].Gastrointest Endosc, 2022, 96(5): 780-786.
|
| [33] |
Matteo MV, Pontecorvi V, Bove V, et al.Prospective, single-arm multicenter, international, observational postmarket study to assess the safety and efficacy of a triangulation platform for treating patients requiring endoscopic gastroplasty[J].Gastrointest Endosc,2025, 101(1): 106-116.e1.
|
| [34] |
Gudur AR, Geng C, Radlinski M, et al.Endoscopic Sleeve Gastroplasty: A Safe Bariatric Intervention for Class III Obesity(BMI > 40)[J].Obes Surg, 2023, 33(4): 1133-1142.
|
| [35] |
Brunaldi VO, Galvao Neto M, Sharaiha RZ, et al.Endoscopic sleeve gastroplasty as an early tool against obesity: a multicenter international study on an overweight population[J].Gastrointest Endosc, 2024, 99(3): 371-376.
|
| [36] |
Verrastro O, Panunzi S, Castagneto-Gissey L, et al.Bariatricmetabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis(BRAVES): a multicentre, open-label,randomised trial[J].Lancet, 2023, 401(10390): 1786-1797.
|
| [37] |
Samarasinghe SNS, Leca B, Alabdulkader S, et al.Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial[J].Lancet, 2024, 403(10443): 2489-2503.
|
| [38] |
Joseph S, Vandruff VN, Amundson JR, et al.Comparable improvement and resolution of obesity-related comorbidities in endoscopic sleeve gastroplasty vs laparoscopic sleeve gastrectomy:single-center study[J].Surg Endosc, 2024, 38(10): 5914-5921.
|
| [39] |
Singh S, Bazarbashi AN, Khan A, et al.Primary obesity surgery endoluminal(POSE) for the treatment of obesity: a systematic review and meta-analysis[J].Surg Endosc, 2022, 36(1): 252-266.
|
| [40] |
Lopez-Nava G, Asokkumar R, Turró Arau R, et al.Modified primary obesity surgery endoluminal(POSE-2) procedure for the treatment of obesity[J].VideoGIE, 2020, 5(3): 91-93.
|
| [41] |
Jense MTF, Hodde T, Palm-Meinders IH, et al.The POSE-2 Procedure for People with Obesity: A Safe and Effective Treatment Option[J].Obes Surg, 2024, 34(10): 3686-3693.
|
| [42] |
Jirapinyo P, Thompson CC.Comparison of distal primary obesity surgery endolumenal techniques for the treatment of obesity(with videos)[J].Gastrointest Endosc, 2022, 96(3): 479-486.
|
| [43] |
Sullivan S, Stein R, Jonnalagadda S, et al.Aspiration therapy leads to weight loss in obese subjects: a pilot study[J].Gastroenterology,2013, 145(6): 1245-1252.e1-5.
|
| [44] |
Swei EC, Sullivan SA.Aspiration Therapy[J].Tech Vasc Interv Radiol, 2020, 23(1): 100659.
|
| [45] |
Thompson CC, Abu Dayyeh BK, Kushnir V, et al.Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial[J].Surg Obes Relat Dis, 2019, 15(8): 1348-1354.
|
| [46] |
Rothstein RI, Kopjar B, Woodman GE, et al.Randomized Double-blind Sham-controlled Trial of a Novel Silicone-filled Endoscopically Placed Device for Weight Loss[J].Techniques and Innovations in Gastrointestinal Endoscopy, 2024, 26(1): 21-29.
|
| [47] |
Richard IR, George W, James S, et al.Transpyloric Shuttle Treatment Improves Cardiometabolic Risk Factors and Quality of Life in Patients with Obesity: Results from a Randomized, Double-Blind,Sham-Controlled Trial[J].Gastroenterology, 2019(6): 1108.
|
| [48] |
Ryder R EJ, Laubner K, Benes M, et al.Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1, 022 Patients Treated Worldwide[J].Diabetes Care, 2023, 46(4): E89-E91.
|
| [49] |
Ruban A, Miras AD, Glaysher MA, et al.Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity:A Multicenter Randomized Controlled Trial[J].Ann Surg, 2022,275(3): 440-447.
|
| [50] |
Boonchaya-Anant P, Bueter M, Gubler C, et al.Sustained weight loss after duodenal-jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study[J].Clin Obes, 2023, 13(1): e12561.
|
| [51] |
Emini M, Bhargava R, Aldhwayan M, et al.Satiety Hormone LEAP2 After Low-Calorie Diet With/Without Endobarrier Insertion in Obesity and Type 2 Diabetes Mellitus[J].J Endocr Soc, 2024, 9(1):bvae214.
|
| [52] |
Machytka E, Bužga M, Zonca P, et al.Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes[J].Gastrointest Endosc, 2017,86(5): 904-912.
|
| [53] |
Biertho L, Marceau S, Nadeau M, et al.Magnetic duodenoileal anastomosis with sleeve gastrectomy: a prospective multicenter study[J].Surg Obes Relat Dis, 2025, 21(2): 166-174.
|
| [54] |
Gagner M, Abuladze D, Buchwald JN, et al.First-in-Human Side-to-Side Duodeno-Ileal Bipartition for Weight Loss and Type 2 Diabetes with the Swallowable Biofragmentable Magnetic Anastomosis System[J].J Am Coll Surg, 2025.
|
| [55] |
Rajagopalan H, Cherrington AD, Thompson CC, et al.Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study[J].Diabetes Care, 2016, 39(12): 2254-2261.
|
| [56] |
Van Baar ACG, Holleman F, Crenier L, et al.Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective,multicentre study[J].Gut, 2020, 69(2): 295-303.
|
| [57] |
Busch CBE, Meiring S, Van Baar ACG, et al.Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label,mechanistic, pilot study[J].Gastrointest Endosc, 2024, 100(3):473-480.e1.
|
| [58] |
Mingrone G, Van Baar AC, Devière J, et al.Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial[J].Gut, 2022, 71(2): 254-264.
|
| [59] |
Imam A, Alim H, Binhussein M, et al.Weight Loss Effect of GLP-1 RAs With Endoscopic Bariatric Therapy and Bariatric Surgeries[J].J Endocr Soc, 2023, 7(12): bvad129.
|
| [60] |
Jirapinyo P, Jaroenlapnopparat A, Thompson CC.Efficacy of anti-obesity medication(AOM) and endoscopic gastric remodeling(EGR): Analysis of combination therapy with optimal timing and agents[J].Endosc Int Open, 2024, 12(12): E1458-e1464.
|
| [61] |
Martines G, Dezi A, Giove C, et al.Efficacy of Intragastric Balloon versus Liraglutide as Bridge to Surgery in Super-Obese Patients[J].Obes Facts, 2023, 16(5): 457-464.
|
| [62] |
Clapp B, Wynn M, Martyn C, et al.Long term(7 or more years)outcomes of the sleeve gastrectomy: a meta-analysis[J].Surg Obes Relat Dis, 2018, 14(6): 741-747.
|
| [63] |
Maselli DB, Alqahtani AR, Abu Dayyeh BK, et al.Revisional endoscopic sleeve gastroplasty of laparoscopic sleeve gastrectomy:an international, multicenter study[J].Gastrointest Endosc, 2021,93(1): 122-130.
|